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ABSTRACT 
 
MicroRNA-128 prevents apoptosis of mesenchymal stem cells by 
targeting Apaf-1  
 
Minji Seung 
 
Department of Medical Science  
The Graduate School, Yonsei University 
 
(Directed by Professor Jong-Chul Park) 
 
Mesenchymal stem cells (MSCs) are highly specialized cells that can be 
derived from bone marrow. The unique qualities of differential and regenerative 
characteristics they possess make them a great tool for heart regeneration after injury. 
However, numerous barricades are lain ahead to pass preceding the pervasive 
application of their clinical use. The steep decrease in their viability upon 
encountering the hostile environment, the abatement of cell proliferation, and the 
augmentation of cell apoptosis occur and jeopardize the attachment and survival of 
MSCs after transplantation. Before MSCs can flaunt their regenerative qualities, the 
guarantee of their survival needs to be ensured. The apoptotic protease activating 
2 
 
factor 1 (Apaf-1), a monomer residing in the cytosol in its inactive form, is a 
molecule that is activated for the assembly of the apoptosome. The apoptosome is 
known to recruit and cleave the initiator caspase-9 to begin the pro-apoptotic 
caspase cascade; thus the abatement of the apoptosome formation was hypothesized 
to be pivotal. To target Apaf-1, we used microRNAs (miRNAs), post-transcriptional 
regulators that bind to complementary sequences in the 3’UTR of mRNAs typically 
resulting in inhibition of mRNA translation or the degradation of mRNAs. In vitro 
results using bone marrow derived human MSCs (hMSCs) showed that when 
hypoxia-stimulated intrinsic apoptosis occured, expression levels of apoptotic 
signals amplified despite no change in Apaf-1. Contrastingly, once hMSCs were 
transfected with specific microRNA-128 (miR-128), expression levels of Apaf-1 and 
apoptosis declined while survival percentages increased indicating that miR-128 can 
regulate Apaf-1 to enhance survival. In accordance to the results, decreased 
detection of Annexin V/PI-labeled cells showed that miR-128 transfected hMSCs 
had lower apoptotic characters signifying higher survival efficacy. In conclusion, 
downregulation of Apaf-1 via miR-128 regulation established a significant decrease 
in apoptosis hence promoted the increase of MSC survival after transplantation. 
 
 
 
Key words: mesenchymal stem cells, apoptosis, Apaf-1, miRNA 
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I. INTRODUCTION 
 
Despite advancement of medical technologies and increasing medical 
knowledge, it is a well-established fact that heart diseases are still one of the 
significant causes of mortality worldwide. 
1
 Amongst them, ischemic heart disease is 
the most typical type of heart disease and the primary cause of heart attacks. 
2
 When 
ischemia occurs in the heart, it confines blood circulation to tissues following the 
restricted pathway, causing impediment of oxygen and nutrients the heart needs in 
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order to function while also creating a favorable environment for accumulation of 
toxins. 
3
 Progressively, the insufficient blood delivery resulting in the limited oxygen 
and nutrient supply and excess toxins, advance to damage or dysfunction of the 
surrounding muscle and tissue. 
3
  
 
In conjunction with everyday expansion of de novo treatments and 
pharmaceutical developments, bone marrow-derived mesenchymal stem cells 
(MSCs) have freshly emerged as an advantageous therapeutic method for heart 
diseases. Because of their secretome secreting abilities 
4
 and multipotency to 
differentiate into various cell types 
5
 such as chondrocytes, neurons, and also 
cardiomyocytes, 
6
 MSCs have promising features as aiding devices to regenerative 
medicine. However, limitations hinder their use in heart therapy as a consequence of 
the hypoxic environmental conditions created by the lack of blood flow to the injury 
region. Poor viability and inefficient engraftment rates after transplantation are the 
biggest constraints for applying the stem cells’ regenerative capability for sufficient 
clinical treatment. 
7
  
 
As mentioned above, a major destructive disclosure to regenerative therapy 
involving stem cells is its survival. Apoptosis, a type of programmed cell death, is 
brought on by the drastic change in environment. Several apoptotic signaling 
pathways cooperatively induce cell apoptosis, leaving only a small percentage of the 
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transplanted MSC to survive. There are two different types of signaling pathways 
that drive cells to apoptosis: the extrinsic apoptotic pathway and the mitochondrial 
intrinsic apoptotic pathway. 
8
 While the extrinsic apoptotic pathway, also known as 
the death receptor pathway, involves the binding of death ligands to its equivalent 
cell surface receptors, 
8
 the mitochondrial intrinsic apoptotic pathway involves 
activation of pro-apoptotic proteins such as Bax, cytochrome c and caspases. 
8
 
Apoptotic protease activating factor 1 (Apaf-1) is a protein involved in the 
mitochondrial intrinsic apoptotic signaling pathway that exists in a monomeric form 
in the cytoplasm in normal conditions. 
9
 When the mitochondria is stimulated by 
apoptosis initiators such as hypoxia and reactive oxygen species (ROS), its 
membrane potential decreases causing the pores to expand, ultimately releasing 
cytochrome c. 
10,11
 Originally confined to the mitochondrial intermembrane space, 
once released into the cytoplasm, cytochrome c binds to the monomeric Apaf-1 to 
form the oligometric apoptosome that recruits the initiator caspase, pro-caspase-9. 
12-
14
 The pro-caspase-9 is then activated, initiating the caspase cascade, resulting in cell 
apoptosis via effector caspase-3 cleavage. 
13
 We hypothesize that silencing of the 
monomeric form of Apaf-1 will result in a domino effect to lower apoptosis. 
Decrease in Apaf-1 will decrease the binding of cytochrome-c despite its release 
from the mitochondria. This will in turn constrict the formation of the apoptosome, 
reducing the onset of the caspase cascade, and postponing apoptosis overall giving 
MSCs a chance to optimize their therapeutic potentials.  
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Recently, microRNAs (miRNA), single stranded noncoding RNA 
molecules of 19-23 nucleotides in size, emerged as tools to mechanically fine-tune a 
variety of cellular phenotypes via inhibition of translation or degradation of target 
messenger RNAs (mRNAs). 
15
 It accomplishes its function by base-pairing with 
complementary sequences within the 3’-untranslated region (3’UTR) of specific 
target mRNAs. Because some miRNAs are known to specifically target cellular 
processes such as apoptosis, 
16-19
 proliferation, 
20,21
 differentiation, 
22-24
 and other 
pivotal regulations, it has become a prevalent molecule in relation to heart diseases 
and stem cell therapy. 
19,25,26
 In this study, miRNAs will be used to regulate the 
expression level of Apaf-1 in hMSCs to decrease apoptosis and in due course, 
promote survival.  
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II. MATERIALS AND METHODS 
 
1. Materials 
Low glucose Dulbecco’s modified eagle’s medium (DMEM), fetal bovine 
serum, phosphate-buffered saline, and penicillin-streptomycin were obtained from 
Gibco by Life Technologies (Seoul, Korea). Apaf-1 antibody was purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Caspase-9 antibody was 
purchased from Cell Signaling (Cell Signaling Technology, Danvers, MA, USA). 
Horseradish peroxidase HRP-conjugated secondary antibodies of mice was obtained 
from Enzo Life Sciences (Farmingdale, NY, USA) while goat was obtained from 
Thermo Scientific (Rockford, IL, USA).  
 
2. Cell culture  
 hMSCs were cultured in DMEM supplemented with 10% FBS, 100 IU/ml 
penicillin and 100 μg/ml streptomycin in 100mm culture plates in 37 C humidified 
incubators with 5% CO2.  
 
3. Cell counting assay 
hMSCs seeded accordingly, were re-suspended in DMEM containing 10% 
FBS and transferred into new 1.5ml tubes containing 0.4% trypan blue staining 
solution. hMSCs were allowed to stand for 5-15 minutes before 10 uL of trypan blue 
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stained cell suspension was transferred to both chambers of a hemocytometer. The 
live cells were unstained and appeared bright while the dead cells were stained blue. 
The live and dead cells were counted separately and cell viability was calculated. 
 
4. Hypoxic stimulation 
To hMSCs seeded accordingly, DMEM was changed to de-gassed serum 
free DMEM before stimulus was given. The airtight humidified hypoxic chamber 
(ThermoForma) was maintained at 37 C and continuously gassed with 1% O2, 5% 
CO2, and 94% N2. 
 
5. MicroRNA transfection  
MiRNA was purchased from Genolution Pharmaceuticals (Genolution Inc., 
Korea). Transfections of miRNAs were performed using TransIT-X2 Dynamic 
Delivery System reagent (Mirus). Briefly, hMSCs were seeded at the density of 7 × 
10
5
 cells per 60mm culture plate. TransIT-X2 Dynamic Delivery System reagent was 
diluted with Opti-MEM and combined accordingly with indicated miRNA mimic for 
each plate and incubated in room temperature for 15-30 minutes to allow sufficient 
formation of complexes. It was then added to each cell plate containing fresh 10% 
FBS-DMEM without antibiotics. After 24h incubation in a 5% CO2 incubator at 
37 °C, appropriate experimentation was carried out. 
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6. Western blot analysis   
hMSCs were washed once in PBS and lysed with lysis buffer (cell 
signaling, Beverly, MA, USA) containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 
mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β-
glycerophosphate, 1 mM Na3VO4, 1 mg/ml leupeptin, and 1 mM PMSF. Protein 
concentrations were determined using the BCA protein assay kit (Thermo, Rockford, 
IL, USA). Proteins were separated in 8%-12% SDS-polyacrylamide gel and 
transferred to PVDF membrane (Millipore Co, Bedford, MA, USA). After transfer 
of the proteins onto the membrane, the membrane was blocked with Tris-buffered 
saline-Tween 20 (TBS-T, 0.1% Tween 20) containing 10% non-fat dried milk 
overnight in 4 °C or 1h in room temperature. The membrane was then washed two 
times with TBS-T and incubated with primary antibodies overnight at 4 °C. The 
membrane was washed three times with TBS-T for 5 min each and incubated for 1 h 
at room temperature with HRP-conjugated secondary antibodies. After extensive 
washing, the bands were detected with enhanced chemiluminescence (ECL) reagent 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). The band intensities were 
quantified using NIH Image J version 1.44p software. 
 
7. Reverse transcription polymerase chain reaction (RT-PCR) 
Total RNA was isolated using 500 μL of RNAiso Plus Total RNA 
Extraction Reagent (Takara) per 60 mm culture plate. In brief, complementary DNA 
10 
 
(cDNA) was synthesized using the Reverse Transcription System (Promega, 
Madison, WI, USA). The single stranded cDNA was synthesized from the isolated 
total RNA via Avian Myeloblastosis virus (AMV) reverse transcriptase. A 20 μl 
reverse transcription reaction mixture containing 1 μg of total RNA, 1X reverse 
transcription buffer (10 mM Tris–HCl, pH 9.0, 50 mM KCl, 0.1% TritonX-100), 1 
mM deoxynucleoside triphosphates (dNTPs) 0.5 U of RNase inhibitor, 0.5 μg of 
oligo(dT), and 15 U of AMV reverse transcriptase was incubated at 42 °C for 15 min, 
heated to 99 °C for 5 min, and then incubated at 0–5 °C for 5 min. PCR was 
performed for 30 cycles with 3′ and 5′ primers based on the sequences of Apaf-1 
gene. GAPDH was used as the internal standard. The signal intensity of the 
amplification product was normalized to its respective GAPDH signal intensity. 
 
8. Real-time polymerase chain reaction (real-time PCR) 
Total RNA was isolated using RNAiso Plus Total RNA Extraction Reagent 
(Takara). In brief, 10 ng of purified total RNA was used for reverse transcription 
(Taqman®  MicroRNA Reverse Transcriptase Kit, Applied Biosystems). The reverse 
transcribed products were then used for Taqman®  MicroRNA Assays for 
quantification of specific miRNAs and U6 control transcripts, according to the 
manufacturer’s conditions. Amplification and detection of specific products were 
performed in a Step One Plus Real Time PCR System (Applied Biosystems) at 95 
C for 10 min followed by 40 cycles of 95 C for 15 sec, and 60 C for 60 sec. The 
11 
 
threshold cycle (Ct) of each target sample, located in the linear amplification phase 
of the PCR, was automatically defined and normalized to the corresponding U6 
value (ΔCt value). The relative difference in expression levels of each miRNA in 
apoptotic hMSCs (ΔΔCt) was calculated and presented as fold inductions (2-ΔΔCt). 
 
9. Immunoprecipitation analysis  
hMSCs were washed once with PBS and lysed in lysis buffer containing 20 
mM Tris (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, and 1 mM Na2EDTA. Protein 
concentrations were determined using the BCA protein assay kit (Thermo, Rockford, 
IL, USA). Quantified proteins were then bound to Dynabeads Protein G (Novex by 
Life Technologies) pre-bound with Apaf-1 antibody in antibody binding buffer, PBS 
with 0.02% Tween 20, for 2 h in room temperature with rotation on rotators. 
Proteins were eluted and denatured using 2X elution buffer containing, 0.2M Tris, 
pH 6.8, 2% SDS, 0.04% Coomassie Blue G250, 40% Glycerol, and β-
Mercaptoethanol, then separated on 8% SDS-polyacrylamide gel and transferred to 
the PVDF membrane (Millipore Co, Bedford, MA, USA). After, the membrane was 
blocked with Tris-buffered saline-Tween 20 (TBS-T, 0.1% Tween 20) containing 10% 
non-fat dried milk overnight at 4 °C. The membrane was then washed two times 
with TBS-T and incubated with primary antibodies overnight at 4 °C. The 
membrane was then washed five times with TBS-T for 5 min each and incubated for 
1 h at room temperature with horseradish peroxidase (HRP)-conjugated secondary 
12 
 
antibodies. After extensive washing, the bands were detected with enhanced 
chemiluminescence (ECL) reagent (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA). The band intensities were quantified using NIH Image J version 1.44p 
software. 
 
10. Cell cytotoxicity assay 
 Membrane integrity was measured using CellTox Green Cytotoxicity Assay 
kit (Promega Corporation, Madison, WI, USA). In brief, hMSCs were plated at 5 × 
10
3
 cells per well. Once attached, 100 μl of 2X reagent containing Assay Buffer with 
2X CellTox Green Dye was distributed to each well and incubated at room 
temperature for 15 minutes, shielded from ambient light. Fluorescence was 
measured at 488nmEx/525nmEm with Varioskan Flash Multimode Reader (Thermo 
Scientific, USA). Each assay was repeated 3 times.  
 
11. Annexin V/PI apoptosis analysis  
Apoptosis was measured using an FITC Annexin V Apoptosis Detection 
Kit I (BD Biosciences). Cells were pelleted and analyzed in the BD Accuri C6 Flow 
Cytometer system. The excitation frequency was 488 nm. The green fluorescents 
emitted by Annexin V (FL1) and the red fluorescents emitted by PI (FL3) were 
measured using 525 nm and 575 nm band pass filters, respectively. A total of at least 
2 × 10
4
 cells were analyzed in each sample. The levels of viable cells, early 
13 
 
apoptotic cells and non-viable cells were measured as percentages of Annexin V-
/PI-, V+/PI- and Annexin V+/PI+ cells, respectively. 
 
12. Statistical analysis   
All quantified data are of means of triplicate samples and the error bars 
represent the standard deviation (STDEV) of the mean. Statistical significance was 
determined by Student’s t-test. Assessments considering more than two groups were 
performed by one-way ANOVA using Bonferroni’s correction. Statistics with P<0.05 
were considered significant.  
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III. RESULTS 
 
1. Change in hMSC viability and expression levels of Apaf-1 in correspondence 
to hypoxic stimulation 
To determine the optimal time for relevant hypoxic stimulation, hMSC 
viability was determined under time dependent hypoxic conditions. Compared to the 
0 h control sample where no hypoxic stimulation was given, there was a significant 
decrease in % cell viability during 3 h, 6 h, 9 h, 12 h, and 24 h of hypoxic 
stimulation (Figure 1). Apaf-1 protein expression levels in hMSCs were also 
determined under time dependent hypoxic stimulation. No significant alterations to 
Apaf-1 protein expression levels were observed (Figure 2).  
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Figure 1. The effect of hypoxic stimulation on hMSC viability. The effects of 
hypoxic stimulation on hMSCs were determined by cell counting. hMSCs were 
stimulated with no hypoxic stimulation under growth conditions of 37 C in 5% CO2 
incubator or 3 h ~ 24 h hypoxic stimulation under growth conditions of 37 C,  
continuously gassed with <1% O2, 5% CO2, and 94% N2. Data are normalized by 0h 
control. Data are presented as the mean value ± STDEV of three separate 
experiments. hMSCs: human mesenchymal stem cells. 
16 
 
 
 
Figure 2. Alteration of hMSC Apaf-1 expression levels in response to hypoxic 
stimulation. The effects of hypoxic stimulation on Apaf-1 protein expression levels 
were determined by western blot analysis. hMSCs were stimulated with no hypoxic 
under growth conditions of 37 C in 5% CO2 incubator stimulation or 3 h ~ 24 h 
hypoxic stimulation under growth conditions of 37 C, continuously gassed with <1% 
O2, 5% CO2, and 94% N2. Data is normalized by β-actin. Data are presented as the 
mean value ± STDEV of three separate experiments. 
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2. Identification of specific miRNA targeting Apaf-1 
Considering that there were no significant changes in the Apaf-1 protein 
levels when given hypoxic stimulation, hMSCs were transfected with candidate 
miRNAs in normal conditions with no hypoxic stimulation in order to determine 
their regulatory effects on Apaf-1. The candidate miRNAs were predicted and 
selected by their aggregate PCT scores assessed through Targetscan online program 
(www.targescan.org) (Figure 3). hMSCs transfected with miR-128 showed 
significant decrease in Apaf-1 protein expression levels compared to the control 
while, on the contrary, miR-27a, miR-27b, and miR-200c showed an increase 
(Figure 4). In correlation to the decreased Apaf-1 protein expression levels, 
improvement of cell viability was observed after 12h of hypoxic stimulation for 
hMSCs transfected with miR-128 (Figure 5). mRNA level detection of Apaf-1 
showed most significant regulatory effects on hMSCs transfected with miR-128 
(Figure 6).  
 
 
 
18 
 
 
 
Figure 3. Potential miRNAs targeting Apaf-1. Candidate miRNAs were found 
using the Targetscan program. 5 miRNAs were selected using their aggregate PCT. 
The location of the 5 miRNAs on the human Apaf-1 3’UTR and their sequences are 
listed. 
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Figure 4. Regulatory effects of candidate miRNAs on Apaf-1 expression levels. 
Effects of miRNA transfection on Apaf-1 protein expression level were determined 
by western blot analysis. Data was normalized by β-actin. Data are presented as the 
mean value ± STDEV of three separate experiments (*P < 0.05).  
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Figure 5. Selective enhancement of hMSC viability after hypoxic stimulation 
following candidate miRNA transfection. Effects of hypoxic stimulation on 
candidate miRNA transfected hMSC survival were determined by cell viability test. 
Data was normalized by control. Data are presented as the mean value ± STDEV of 
three separate experiments (*P < 0.05). 
 
 
21 
 
 
 
Figure 6. Possible Apaf-1 mRNA degradation of hMSCs transfected with 
selective candidate miRNAs. Effects of miRNA transfection on Apaf-1 mRNA 
expression levels were determined by RT-PCR. Data was normalized by GAPDH. 
Data are presented as the mean value ± STDEV of three separate experiments (*P < 
0.05). 
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3. microRNA-128 directly targets Apaf-1 in hMSCs  
With intention to link the Apaf-1 protein levels and its regulation via miR-
128, the unchanging protein levels of Apaf-1 in hypoxic conditions was compared to 
the miR-128 levels. Real-time PCR was performed to determine the relative 
expression levels of miR-128 in a time dependent matter. As predicted, the relative 
expression levels of miR-128 did not change in correspondence to the protein 
expression levels of Apaf-1. The changes only conferred an auto-regulatory 
fluctuation (Figure 7).  
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Figure 7. The effect of hypoxic stimulation on relative expression levels of miR-
128. Effect of hypoxic stimulation on relative expression levels of miR-128 was 
determined by real-time PCR. Samples were prepared under time dependent hypoxic 
stimulation. Data are presented as the mean value ± STDEV of three separate 
experiments. 
 
 
 
24 
 
4. Particular microRNA-128 attenuation of apoptosome formation through 
Apaf-1 regulation 
Along with confirmation of direct regulation of Apaf-1 via miR-128, 
apoptosome formation control was also established. hMSCs transfected with miR-
128 were given hypoxic stimulation for 12h. Caspase-9 was detected after being 
immunoprecipitated by Apaf-1 via Dynabead extraction. In the immunoprecipitated 
samples, distinct amount of caspase-9 bound to Apaf-1 decreased in miR-128 
transfected hMSCs stimulated with 12h of hypoxia (Figure 8). The whole cell lysate 
western blot samples and immunoprecipitated samples correlated in that the active 
form of caspase-9, more distinct in the immunoprecipitated sample, decreased in 
hMSCs transfected with miR-128. The decreased overall caspase-9 suggests that 
there were less protein-protein bound complexes formed between Apaf-1 and 
caspase-9 signifying that the Apaf-1 / cytochrome c conformed apoptosome 
formation was interrupted by the decrease in Apaf-1 via miR-128 regulation, thus 
lessening the recruitment of pro-caspase-9 (Figure 8). 
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Figure 8. Specific inhibition of apoptosome formation after hypoxic stimulation 
via miR-128 transfection. Immunoprecipitation results showing decreased levels of 
caspase-9 interacting with Apaf-1. Samples were immunoprecipitated with Apaf-1 
specific antibodies and blotted with caspase-9 antibody using Dynabeads. 
Immunoprecipitation data was normalized by Apaf-1 while whole cell lysate data 
was normalized by β-actin. Data are presented as the mean value ± STDEV of three 
separate experiments (*P < 0.05). 
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5. miRNA-128 suppresses apoptosis in hypoxia stimulated hMSCs 
In consideration of apoptosis regulation via suppressing Apaf-1 with miR-
128, cell cytotoxicity was validated. The dramatically increased change in 
membrane integrity was observed when given hypoxic stimulation but only small 
changes to the membrane integrity was observed in hMSCs transfected with miR-
128 (Figure 9). In equivalence to the decreased change in membrane integrity, 
reduction of cells showing late apoptotic characters confirmed that targeting Apaf-1 
with miR-128 transfection ultimately reduced overall apoptosis (Figure 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
 
 
Figure 9. Sequential downregulation of cell cytotoxicity of miR-128 transfected 
hMSCs with hypoxic stimulation. Effects of miR-128 transfection on hMSC 
membrane integrity due to toxin accumulation after hypoxic stimulation. Data are 
presented as the mean value ± STDEV of three separate experiments (*P < 0.05). 
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Figure 10. Inhibition of hMSC death via miR-128 trnasfetion. Effects of miR-
128 transfection on overall apoptosis after hypoxic stimulation. Graph shows 
quantification of late apoptotic cells that are Annexin V+, PI+. Data was normalized 
by control. Data are presented as the mean value ± STDEV of three separate 
experiments (*P < 0.05). 
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IV. DISCUSSION 
 
Apaf-1 is a molecule that is associated with the assembly of the pro-
apoptotic apoptosome formation. 
9
 The importance of Apaf-1 and its role in 
apoptosis regulation via formation of the apoptosome, have been intensely studied in 
the past. 
27,28
 It normally resides in the cytosol in its monomeric form until it is 
coupled with the mitochondria secreted cytochrome c to form the caspase-9 
recruiting apoptosome. 
13
 Once the apoptosome is formed, it initiates the caspase 
cascade via activation of initiator caspase-9. 
29
 In order to decrease hMSC apoptosis, 
we targeted the Apaf-1 molecule with miRNA regulation. In this study, our research 
suggests that expression levels of Apaf-1 were successfully decreased by miR-128 
regulation and that overall apoptosis decreased consequentially.  
 
Although Apaf-1 is known to be a key regulatory molecule of apoptosis, 
limited amount of studies are done on hMSC Apaf-1 regulation. Apaf-1 is solely 
related to the intrinsic mitochondria mediated apoptotic pathway, and is a naturally 
existing cytosolic molecule. 
13
 Because of its original existence, its expression levels 
may not show variations with hypoxic stimulations but only conform to its active 
form. Accordingly, despite no apparent increase to its expression levels under time 
dependent hypoxic stimulation, the degradation of Apaf-1 mRNA resulted in the 
decrease of ultimate apoptosis. Obstructing the apoptotic pathway midway increased 
30 
 
hMSC survival. This in turn gives hMSCs a chance to adapt to the hypoxic 
environment and carry out their initial purpose of regenerative therapy via 
differentiation, recruitment and differentiation of pre-existing cardiac stem cells, 
self-renewal, secretion of secretomes, etc. Another interpretation of the data can 
suggest that not a sufficient amount of apoptosis can be regulated with only targeting 
one molecule of the intrinsic apoptotic pathway. However, because miRNAs can be 
multi-targeting and because our research can contribute to future studies, the 
interpreted data may not be conclusive.  
 
Many miRNAs have been discovered to regulate many cellular processes.  
Some miRNAs such as miR-17-92 cluster, miR-21, miR133, and miR-221/222 are 
well-known examples of anti-apoptosis regulators. 
30
 However, specific roles and 
mechanisms of many contributing to stem cell therapy and cardiovascular diseases 
still remain to be determined. MiR-128 is a well-known miRNA that plays an 
important role in tumor genesis and cancer development. 
31
 It is also considered to 
be an effective target for malignant tumor therapy. 
31
 However, there have not been 
any previous studies done in linking miR-128 and Apaf-1 in hMSCs altogether.  
 
 Although there has been studies done on caspase-9 activation through an 
endoplasmic reticulum stress specific apoptotic pathway independent of the 
apoptosome formation, 
32
 the percentage of its influence is still to be determined. 
31 
 
Meanwhile, pro-caspase-9 recruitment by the apoptosome remains to be the main 
mechanism proven to lead to cell apoptosis. In order to validate the decrease in the 
hallmark protein-protein interaction between Apaf-1 and caspase-9 and apoptosome 
formation, the interacting proteins were extracted as a whole through an 
immunoprecipiation technique. Results showed decreased pro-form of caspase-9 in 
samples of hMSCs transfected with miR-128 without any detection of the active 
caspase-9. While there are only just speculations about what the structure of the 
apoptosome might be, 
29
 no studies show visual data of the actual detection of the 
apoptosome structure, let alone the decrease of the complex iteself. Caspase-9’s 
unique character that involves its recruitment by the Apaf-1/cytochrome c 
conformed apoptosome allows us to pin point the decrease in apoptosome formation 
indirectly without physically visualizing the decrease in the structure.  
 
 Another major type of programmed cell death that cannot be ignored when 
it comes to hMSC survival after it encounters hypoxic conditions is necrosis. 
Although necrosis is known to occur after physicochemical or physical cellular 
stress stimuli, 
33
 hypoxia can also bring on necrosis. 
34,35
 However, because our study 
focuses on apoptosis and its regulations via targeting the Apaf-1 molecule, we 
quantified cells that were only in the late apoptotic stage: Annexin V+, PI+ cells. 
Further studies can be based on finding multi-targeting miRNAs that target multiple 
factors that is involved in necrosis, apoptosis, and even pyroptosis in order to 
32 
 
effectively reduce cell death in the future.  
 Overall, our research demonstrates promising outcomes of miR-128 on 
hMSC apoptosis. With further elaborative studies regarding this current study, 
disclosure of miR-128 as a beneficial therapeutic tool for future heart regenerative 
stem cell therapy can be expected.  
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V. CONCLUSION 
 
The cumulating results suggest that microRNA-128 can be incorporated 
alone or in combination with other factors to regulate Apaf-1. The overall results of 
this study validates that Apaf-1 is a key regulator of the intrinsic mitochondria-
mediated apoptotic pathway that is responsible for the survival of hMSCs in face of 
hypoxic environment. Repression of Apaf-1 using transfection of miR-128 promoted 
hMSC survival. Hence, miR-128 can be used as a novel treatment method for 
injured hearts via augmentation of hMSC survival. 
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ABSTRACT (in Korean) 
 
Apaf-1을 타깃으로 하는 microRNA-128을 이용한 중간엽 줄기세포 
사멸 억제 
 
<지도교수 박 종 철> 
 
연세대학교 대학원 의과학과 
승 민 지 
 
 중간엽 줄기세포는 골수에서 유래한 특화된 세포 중 뛰어난 
분화능, 재생능력에 기여하는 secretome의 분비를 통한 주면 세포의 
회복등과 같은 특성을 같고 있다고 알려져 있다. 이러한 중간엽 
줄기세포의 특성들은 손상된 심장의 재생치료에 유용한 도구로 사용될 수 
있다. 하지만 이를 보편적으로 응용, 또는 사용하기에 앞서 선결해야 할 
여러 장애물이 있다. 심근경색과 같은 심장 질환의 경우, 일반적으로 
가혹한 저산소 조건 하에서의 세포사멸을 방지할 수 있는 방법을 
모색하였다. 세포사멸 과정에서 중요한 역할을 하는 인자 중 하나인 
Apaf-1은 세포기질에 원래 존재하며 cytochrome c와 결합하여 
40 
 
apoptosome의 형성에 기여한다. 이렇게 형성된 apoptosome은 비활성상태의 
pro-caspase-9을 불러들여 효소적 절단 과정을 통해 활성화 상태의 caspase-
9을 만들게 되며 이는 추가적인 세포사멸 기전을 전파하게 된다. 따라서 
본 연구에서는 Apaf-1의 생성을 이러한 신호전달 기전의 전파를 억제할 
것이라는 가설을 세워 그를 검증하고자 하였다. Apaf-1의 발현 억제를 
위해서는 microRNA를 사용하였는데 miRNA는 표적 유전자의 
3’UTR부분에 상보적으로 결합해 표적 유전자의 발현을 억제하는 post-
transcriptional regulator로 알려져 있다. 본 연구 결과에 따르면 인간 
골수에서 채취된 중간엽 줄기세포에 저산소 자극을 주었을 때 Apaf-1에 
의한 apoptosome 형성이 증가하여 세포 사멸이 증가하는 것이 관찰되었다. 
Apaf-1을 표적으로 하는 miRNA인 MIR-128을 전처리 할 경우 낮아진 
Apaf-1의 발현과 apoptosome 형성에 의존하여 인간 중간엽 줄기세포의 
생존율 역시 향상되는 것을 확인하였다. 본 연구의 결과는 세포사멸의 
주요 인자 중 하나인 Apaf-1의 발현을 miRNA를 통해 억제하는 것이 
저산소 조건 하에서 중간엽 줄기세포의 생존을 높이는데 기여한다는 것을 
보여주며, 이러한 접근 방식은 기존 세포치료의 난제 중 하나인 이식 후 
낮은 생존율을 높이는데 유용하게 사용될 수 있을 것으로 기대된다.  
 
핵심 되는 말: 중간엽 줄기세포, 세포 사멸, Apaf-1, miRNA  
